Patent ID: 8394759

Claim:
A transdermal delivery composition containing one or more active agents in a carrier comprising: a) four or more cetylated compounds in combinations best suited for the permeation of said active agent through the skin; said cetylated compounds are present at a combined concentration ranging from 4-20% and are selected from the group consisting of cetyl arginine, cetyl 11-cyclohexylundecanoate, cetyl decanoate, cetyl dihomo-y-linolenate, cetyl docosapentanoate, cetyl eicosapentanoate, cetyl isolaurate, cetyl isomyristate, cetyl laurate, cetyl linolenate, cetyl 2-methoxy-5-hexadecenoate, cetyl 13-methyl myristate, cetyl myristoleate, cetyl myristate, cetyl oleate, cetyl ornithine, cetyl palmitate, cetyl palmitoleate, cetyl stearate, cetyl stearidonate and cetyl vaccenate; and b) one or more polar solvents present in combined concentrations ranging from 5-30%, wherein the solvents are selected from the group consisting of 1,2,4-butane triol, dimethicone copolyol, ethanol, ethylene glycol, glycerol, glyceryl monostearate, 1,2,6-hexane triol, isopropanol, polyethylene glycol and propylene glycol; Wherein said cetylated compounds and polar solvents are of suitable combinations so as to provide effective transdermal delivery of the active agent.